{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:45:19Z","timestamp":1790023519883,"version":"4.0.1"},"reference-count":91,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Liver fibrosis, which is characterized by the excessive deposition of extracellular matrix (ECM) materials (primarily fibrillar collagen-I), is an abnormal repair reaction and pathological outcome of chronic liver diseases caused by alcohol abuse, non-alcoholic fatty liver disease, and chronic hepatitis B and C virus infections. Liver fibrosis often progresses to liver cirrhosis and hepatocellular carcinoma. Ferroptosis, characterized by lipid peroxidation, is a form of iron-dependent non-apoptotic cell death, and recent studies have reported that ferroptosis contribute to the development of liver fibrosis. Moreover, several agents have demonstrated therapeutic effects in experimental liver fibrosis models by inducing hepatic stellate cell (HSCs) ferroptosis. This review delineates the specific mechanism by which ferroptosis contributes to the development of liver fibrosis. Specifically, we focused on the different types of therapeutic agents that can induce HSCs ferroptosis and summarize their pharmacological effectiveness for liver fibrosis treatment. We suggest that HSCs ferroptosis may be a potential useful target of novel therapies for preventing and treating liver fibrosis.<\/jats:p>","DOI":"10.3389\/fphar.2022.1071844","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T18:45:32Z","timestamp":1673376332000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacological modulation of ferroptosis as a therapeutic target for liver fibrosis"],"prefix":"10.3389","volume":"13","author":[{"given":"Le","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/0006-291x(77)90623-4","article-title":"Effect of antioxidants on cultured human diploid fibroblasts exposed to cystine-free medium","volume":"74","author":"Bannai","year":"1977","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1172\/JCI24282","article-title":"Liver fibrosis","volume":"115","author":"Bataller","year":"2005","journal-title":"J. Clin. Invest."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1002\/wsbm.1499","article-title":"Liver fibrosis: Pathophysiology and clinical implications","volume":"13","author":"Berumen","year":"2021","journal-title":"WIREs Mech. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"5390","DOI":"10.4049\/jimmunol.175.8.5390","article-title":"TGF-beta and Smad3 signaling link inflammation to chronic fibrogenesis","volume":"175","author":"Bonniaud","year":"2005","journal-title":"J. Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41418-022-00941-0","article-title":"The multifaceted role of ferroptosis in liver disease","volume":"29","author":"Chen","year":"2022","journal-title":"Cell. Death Differ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e20210518","DOI":"10.1084\/jem.20210518","article-title":"Ferroptosis in infection, inflammation, and immunity","volume":"218","author":"Chen","year":"2021","journal-title":"J. Exp. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/sj.bjp.0706172","article-title":"Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis","volume":"145","author":"de Gouville","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1177\/1535370219898141","article-title":"Mechanisms of liver fibrosis and its role in liver cancer","volume":"245","author":"Dhar","year":"2020","journal-title":"Exp. Biol. Med. (Maywood, N.J.)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell."},{"key":"B10","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1126\/science.122.3168.501","article-title":"Nutrition needs of mammalian cells in tissue culture","volume":"122","author":"Eagle","year":"1955","journal-title":"Science"},{"key":"B11","doi-asserted-by":"publisher","first-page":"133","DOI":"10.15171\/mejdd.2018.103","article-title":"New concepts on reversibility and targeting of liver fibrosis; A review article","volume":"10","author":"Ebrahimi","year":"2018","journal-title":"Middle East J. Dig. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","article-title":"Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis","volume":"178","author":"Fallowfield","year":"2007","journal-title":"J. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/antiox9121254","article-title":"Looking back at the early stages of redox biology","volume":"9","author":"Floh\u00e9","year":"2020","journal-title":"Antioxidants (Basel)"},{"key":"B14","doi-asserted-by":"publisher","first-page":"S38","DOI":"10.1016\/s0168-8278(02)00429-4","article-title":"Liver fibrosis - from bench to bedside","volume":"38","author":"Friedman","year":"2003","journal-title":"J. Hepatol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/hep.32285","article-title":"Hepatic fibrosis 2022: Unmet needs and a blueprint for the future","volume":"75","author":"Friedman","year":"2022","journal-title":"Hepatology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.jhep.2017.06.001","article-title":"Hepatic stellate cell activation and pro-fibrogenic signals","volume":"67","author":"Gandhi","year":"2017","journal-title":"J. Hepatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: Pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1038\/cr.2016.95","article-title":"Ferroptosis is an autophagic cell death process","volume":"26","author":"Gao","year":"2016","journal-title":"Cell. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1055\/s-2001-17550","article-title":"History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells","volume":"21","author":"Geerts","year":"2001","journal-title":"Semin. Liver Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"G319","DOI":"10.1152\/ajpgi.00097.2017","article-title":"Loss of cellular FLICE-inhibitory protein promotes acute cholestatic liver injury and inflammation from bile duct ligation","volume":"314","author":"Gehrke","year":"2018","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.jhep.2021.02.012","article-title":"Targeting cell-intrinsic metabolism for antifibrotic therapy","volume":"74","author":"Gilgenkrantz","year":"2021","journal-title":"J. Hepatol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.cell.2020.04.039","article-title":"SnapShot: Ferroptosis","volume":"181","author":"Hadian","year":"2020","journal-title":"Cell."},{"key":"B23","doi-asserted-by":"publisher","first-page":"11392","DOI":"10.1074\/jbc.M310284200","article-title":"Peroxisome proliferator-activated receptor gamma induces a phenotypic switch from activated to quiescent hepatic stellate cells","volume":"279","author":"Hazra","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B24","doi-asserted-by":"publisher","first-page":"101470","DOI":"10.1016\/j.molmet.2022.101470","article-title":"Ferroptosis and ferritinophagy in diabetes complications","volume":"60","author":"He","year":"2022","journal-title":"Mol. Metab."},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/s0168-8278(99)80010-5","article-title":"The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo","volume":"30","author":"Hellerbrand","year":"1999","journal-title":"J. Hepatol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6671129","DOI":"10.1155\/2021\/6671129","article-title":"Wild bitter melon extract regulates LPS-induced hepatic stellate cell activation, inflammation, endoplasmic reticulum stress, and ferroptosis","volume":"2021","author":"Ho","year":"2021","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"B28","doi-asserted-by":"publisher","first-page":"154117","DOI":"10.1016\/j.phymed.2022.154117","article-title":"Isoliquiritigenin alleviates liver fibrosis through caveolin-1-mediated hepatic stellate cells ferroptosis in zebrafish and mice","volume":"101","author":"Huang","year":"2022","journal-title":"Phytomedicine"},{"key":"B29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1172\/JCI30542","article-title":"Models of liver fibrosis: Exploring the dynamic nature of inflammation and repair in a solid organ","volume":"117","author":"Iredale","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B30","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s12272-020-01273-8","article-title":"Emerging roles of ferroptosis in liver pathophysiology","volume":"43","author":"Kim","year":"2020","journal-title":"Arch. Pharm. Res."},{"key":"B31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","article-title":"Molecular and cellular mechanisms of liver fibrosis and its regression","volume":"18","author":"Kisseleva","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1016\/j.biopha.2018.11.030","article-title":"Artesunate alleviates liver fibrosis by regulating ferroptosis signaling pathway","volume":"109","author":"Kong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1172\/JCI88845","article-title":"Mesothelin\/mucin 16 signaling in activated portal fibroblasts regulates cholestatic liver fibrosis","volume":"127","author":"Koyama","year":"2017","journal-title":"J. Clin. Invest."},{"key":"B34","doi-asserted-by":"publisher","first-page":"113869","DOI":"10.1016\/j.addr.2021.113869","article-title":"Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis","volume":"176","author":"Kumar","year":"","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B35","doi-asserted-by":"publisher","first-page":"113888","DOI":"10.1016\/j.addr.2021.113888","article-title":"Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis","volume":"176","author":"Kumar","year":"","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B36","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jphs.2020.07.014","article-title":"Chrysophanol attenuates Hepatitis B virus X protein-induced hepatic stellate cell fibrosis by regulating endoplasmic reticulum stress and ferroptosis","volume":"144","author":"Kuo","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.jhep.2018.12.003","article-title":"Fibrosis and alcohol-related liver disease","volume":"70","author":"Lackner","year":"2019","journal-title":"J. Hepatol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e0129743","DOI":"10.1371\/journal.pone.0129743","article-title":"Deficiency of NOX1 or NOX4 prevents liver inflammation and fibrosis in mice through inhibition of hepatic stellate cell activation","volume":"10","author":"Lan","year":"2015","journal-title":"PLoS ONE"},{"key":"B39","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1038\/s41598-017-03389-2","article-title":"Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cells","volume":"7","author":"Lee","year":"2017","journal-title":"Sci. Rep."},{"key":"B40","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","article-title":"Targeting ferroptosis as a vulnerability in cancer","volume":"22","author":"Lei","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"102435","DOI":"10.1016\/j.redox.2022.102435","article-title":"Ferroportin-dependent ferroptosis induced by ellagic acid retards liver fibrosis by impairing the SNARE complexes formation","volume":"56","author":"Li","year":"2022","journal-title":"Redox Biol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1002\/ptr.7558","article-title":"Wogonoside attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis through SOCS1\/P53\/SLC7A11 pathway","volume":"36","author":"Liu","year":"","journal-title":"Phytother. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"933732","DOI":"10.3389\/fphar.2022.933732","article-title":"The critical role of ferritinophagy in human disease","volume":"13","author":"Liu","year":"","journal-title":"Front. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijbiomac.2022.05.041","article-title":"ASIC1a promotes hepatic stellate cell activation through the exosomal miR-301a-3p\/BTG1 pathway","volume":"211","author":"Luan","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3748\/wjg.v27.i14.1419","article-title":"Lipotoxic hepatocyte-derived exosomal miR-1297 promotes hepatic stellate cell activation through the PTEN signaling pathway in metabolic-associated fatty liver disease","volume":"27","author":"Luo","year":"","journal-title":"World J. Gastroenterol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.omtn.2021.10.022","article-title":"Hepatocyte-derived exosomal miR-27a activateshepatic stellate cells through the inhibitionof PINK1-mediated mitophagy in MAFLD","volume":"26","author":"Luo","year":"","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"B49","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1080\/10717544.2022.2030428","article-title":"Mesenchymal stem cell-originated exosomal circDIDO1 suppresses hepatic stellate cell activation by miR-141-3p\/PTEN\/AKT pathway in human liver fibrosis","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"key":"B50","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/nature13148","article-title":"Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy","volume":"509","author":"Mancias","year":"2014","journal-title":"Nature"},{"key":"B51","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"B52","first-page":"211","article-title":"Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione","volume":"187","author":"Mitchell","year":"1973","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B53","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jhep.2013.12.005","article-title":"A TLR2\/S100A9\/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse","volume":"60","author":"Moles","year":"2014","journal-title":"J. Hepatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.7150\/ijms.62903","article-title":"Ferroptosis and liver fibrosis","volume":"18","author":"Pan","year":"2021","journal-title":"Int. J. Med. Sci."},{"key":"B56","doi-asserted-by":"publisher","first-page":"111342","DOI":"10.1016\/j.biopha.2021.111342","article-title":"Advances in the research of nanodrug delivery system for targeted treatment of liver fibrosis","volume":"137","author":"Peng","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"B57","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.jhep.2011.04.008","article-title":"Targeted therapy of liver fibrosis\/cirrhosis and its complications","volume":"55","author":"Poelstra","year":"2011","journal-title":"J. Hepatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1139\/bcb-2022-0027","article-title":"Decursin ameliorates carbon tetrachloride-induced liver fibrosis by facilitating ferroptosis of hepatic stellate cells","volume":"100","author":"Que","year":"2022","journal-title":"Biochem. Cell. Biol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3390\/cells9040875","article-title":"Liver fibrosis: Mechanistic concepts and therapeutic perspectives","volume":"9","author":"Roehlen","year":"2020","journal-title":"Cells"},{"key":"B60","doi-asserted-by":"publisher","first-page":"515","DOI":"10.3390\/cells10030515","article-title":"Heme oxgenase-1, a cardinal modulator of regulated cell death and inflammation","volume":"10","author":"Ryter","year":"2021","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jhep.2017.11.012","article-title":"Determinants of fibrosis progression and regression in NASH","volume":"68","author":"Schuppan","year":"2018","journal-title":"J. Hepatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0083-6729(06)75006-3","article-title":"Vitamin A-storing cells (stellate cells)","volume":"75","author":"Senoo","year":"2007","journal-title":"Vitam. Horm."},{"key":"B63","doi-asserted-by":"publisher","first-page":"4959","DOI":"10.1074\/jbc.M410078200","article-title":"Adipogenic transcriptional regulation of hepatic stellate cells","volume":"280","author":"She","year":"2005","journal-title":"J. Biol. Chem."},{"key":"B64","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.freeradbiomed.2022.02.028","article-title":"m(6 A methylation is required for dihydroartemisinin to alleviate liver fibrosis by inducing ferroptosis in hepatic stellate cells","volume":"182","author":"Shen","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"B65","doi-asserted-by":"publisher","first-page":"102151","DOI":"10.1016\/j.redox.2021.102151","article-title":"N6-methyladenosine modification regulates ferroptosis through autophagy signaling pathway in hepatic stellate cells","volume":"47","author":"Shen","year":"2021","journal-title":"Redox Biol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3390\/ph15070896","article-title":"Phloridzin reveals new treatment strategies for liver fibrosis","volume":"15","author":"Shi","year":"2022","journal-title":"Pharm. (Basel)"},{"key":"B67","doi-asserted-by":"publisher","first-page":"8334","DOI":"10.1080\/21655979.2022.2051858","article-title":"Liraglutide attenuates hepatic iron levels and ferroptosis in db\/db mice","volume":"13","author":"Song","year":"2022","journal-title":"Bioengineered"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell."},{"key":"B69","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.biopha.2018.06.060","article-title":"Magnesium isoglycyrrhizinate ameliorates liver fibrosis and hepatic stellate cell activation by regulating ferroptosis signaling pathway","volume":"106","author":"Sui","year":"2018","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1586\/egh.11.92","article-title":"Update on hepatic stellate cells: Pathogenic role in liver fibrosis and novel isolation techniques","volume":"6","author":"Tacke","year":"2012","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"B71","doi-asserted-by":"publisher","first-page":"730176","DOI":"10.3389\/fcell.2021.730176","article-title":"Liver fibrosis: Therapeutic targets and advances in drug therapy","volume":"9","author":"Tan","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"R1292","DOI":"10.1016\/j.cub.2020.09.068","volume":"30","author":"Tang","year":"2020","journal-title":"Ferroptosis. Curr. Biol."},{"key":"B73","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0005-2760(82)90150-3","article-title":"Purification from pig liver of a protein which protects liposomes and biomembranes from peroxidative degradation and exhibits glutathione peroxidase activity on phosphatidylcholine hydroperoxides","volume":"710","author":"Ursini","year":"1982","journal-title":"Biochim. Biophys. Acta"},{"key":"B74","doi-asserted-by":"publisher","first-page":"787748","DOI":"10.3389\/fphar.2022.787748","article-title":"Molecular mechanisms and potential new therapeutic drugs for liver fibrosis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/iub.1895","article-title":"P53-dependent induction of ferroptosis is required for artemether to alleviate carbon tetrachloride-induced liver fibrosis and hepatic stellate cell activation","volume":"71","author":"Wang","year":"2019","journal-title":"IUBMB Life"},{"key":"B76","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell. Metab."},{"key":"B77","doi-asserted-by":"publisher","first-page":"102131","DOI":"10.1016\/j.redox.2021.102131","article-title":"Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis","volume":"46","author":"Wu","year":"","journal-title":"Redox Biol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41420-021-00660-4","article-title":"Ferroptosis in liver disease: New insights into disease mechanisms","volume":"7","author":"Wu","year":"","journal-title":"Cell. Death Discov."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1002\/hep.26511","article-title":"Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice","volume":"58","author":"Xie","year":"2013","journal-title":"Hepatology"},{"key":"B80","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/s41420-021-00768-7","article-title":"Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis","volume":"7","author":"Yi","year":"2021","journal-title":"Cell. Death Discov."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/cpr.13158","article-title":"Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway","volume":"55","author":"Yuan","year":"2022","journal-title":"Cell. Prolif."},{"key":"B82","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/biof.1764","article-title":"Dihydroartemisinin alleviates hepatic fibrosis through inducing ferroptosis in hepatic stellate cells","volume":"47","author":"Zhang","year":"2021","journal-title":"Biofactors"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1080\/15548627.2019.1687985","article-title":"RNA-binding protein ZFP36\/TTP protects against ferroptosis by regulating autophagy signaling pathway in hepatic stellate cells","volume":"16","author":"Zhang","year":"","journal-title":"Autophagy"},{"key":"B84","doi-asserted-by":"publisher","first-page":"101619","DOI":"10.1016\/j.redox.2020.101619","article-title":"The BRD7-P53-SLC25A28 axis regulates ferroptosis in hepatic stellate cells","volume":"36","author":"Zhang","year":"","journal-title":"Redox Biol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1080\/15548627.2018.1503146","article-title":"Activation of ferritinophagy is required for the RNA-binding protein ELAVL1\/HuR to regulate ferroptosis in hepatic stellate cells","volume":"14","author":"Zhang","year":"2018","journal-title":"Autophagy"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e22665","DOI":"10.1096\/fj.202200933RR","article-title":"Curcumol alleviates liver fibrosis through inducing autophagy and ferroptosis in hepatic stellate cells","volume":"36","author":"Zheng","year":"2022","journal-title":"FASEB J."},{"key":"B87","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/1061186X.2022.2044485","article-title":"Combination therapy based on targeted nano drug co-delivery systems for liver fibrosis treatment: A review","volume":"30","author":"Zhou","year":"","journal-title":"J. Drug Target"},{"key":"B88","doi-asserted-by":"publisher","first-page":"928321","DOI":"10.3389\/fmolb.2022.928321","article-title":"Ferroptosis in chronic liver diseases: Opportunities and challenges","volume":"9","author":"Zhou","year":"","journal-title":"Front. Mol. Biosci."},{"key":"B89","doi-asserted-by":"publisher","first-page":"eaat0344","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B90","doi-asserted-by":"publisher","first-page":"644901","DOI":"10.3389\/fcell.2021.644901","article-title":"TRIM26 induces ferroptosis to inhibit hepatic stellate cell activation and mitigate liver fibrosis through mediating SLC7A11 ubiquitination","volume":"9","author":"Zhu","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","article-title":"Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis","volume":"16","author":"Zou","year":"2020","journal-title":"Nat. Chem. Biol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1071844\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T18:45:36Z","timestamp":1673376336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.1071844\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":91,"alternative-id":["10.3389\/fphar.2022.1071844"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.1071844","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1071844"}}